Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ

$--

(--)

Pre-Market

Apellis Pharmaceuticals, Inc. (APLS) Live Price Chart

Last updated: ⁦2026-09-16 13:20:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Apellis Pharmaceuticals, Inc. (APLS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Apellis Pharmaceuticals, Inc. (APLS) Pre-Market Stock Price

Apellis Pharmaceuticals, Inc. (APLS) is trading at $-- in pre-market trading as of --, -- from the previous close of $--

Pre-market trading shows how investors are pricing APLS before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.

Apellis Pharmaceuticals, Inc. (APLS) 7-Day Stock Price Change

Over the past seven days, Apellis Pharmaceuticals, Inc. (APLS) moved from $40.95 to $41.03, representing a gain of 0.20% ($0.08).

The stock traded between $40.93 and $41.14 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 15.37 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Apellis Pharmaceuticals, Inc. (APLS)?

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).

Apellis Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	733
Exchange	NASDAQ
Company Website	https://www.apellis.com

How to Buy Apellis Pharmaceuticals, Inc. (APLS) Stock on MEXC

Eligible investors can buy real shares of Apellis Pharmaceuticals, Inc. (APLS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for APLS and Place Your Order

Open the RealStocks trading page and search for APLS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Apellis Pharmaceuticals, Inc. (APLS) stock price today?

Apellis Pharmaceuticals, Inc. (APLS) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is APLS stock going up or down today?

As of --, APLS is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is APLS pre-market price?

As of --, APLS is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is APLS after-hours price?

As of --, APLS is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is APLS stock trading now?

APLS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does APLS sit relative to its 52-week high and low?

Over the past 52 weeks, APLS has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Apellis Pharmaceuticals, Inc. in?

Apellis Pharmaceuticals, Inc. (APLS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Apellis Pharmaceuticals, Inc.'s market capitalisation and where is it listed?

Apellis Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalisation of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is APLS valued in terms of P/E ratio and EPS?

APLS trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Apellis Pharmaceuticals, Inc. pay a dividend?

Apellis Pharmaceuticals, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.